XTX Topco’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,010
| Closed | -$1.18M | – | 2438 |
|
|
2024
Q4 | $1.18M | Buy |
18,010
+11,112
| +161% | +$730K | 0.1% | 208 |
|
|
2024
Q3 | $485K | Buy |
6,898
+1,880
| +37% | +$132K | 0.04% | 839 |
|
|
2024
Q2 | $413K | Sell |
5,018
-6,121
| -55% | -$504K | 0.04% | 753 |
|
|
2024
Q1 | $973K | Buy |
11,139
+9,029
| +428% | +$789K | 0.13% | 170 |
|
|
2023
Q4 | $203K | Sell |
2,110
-7,631
| -78% | -$736K | 0.04% | 950 |
|
|
2023
Q3 | $862K | Sell |
9,741
-6,339
| -39% | -$561K | 0.15% | 146 |
|
|
2023
Q2 | $1.39M | Buy |
+16,080
| New | +$1.39M | 0.25% | 41 |
|
|
2023
Q1 | – | Sell |
-3,484
| Closed | -$361K | – | 1284 |
|
|
2022
Q4 | $361K | Buy |
+3,484
| New | +$361K | 0.08% | 464 |
|
|
2022
Q3 | – | Sell |
-4,038
| Closed | -$335K | – | 1109 |
|
|
2022
Q2 | $335K | Sell |
4,038
-3,756
| -48% | -$312K | 0.14% | 233 |
|
|
2022
Q1 | $601K | Buy |
7,794
+4,771
| +158% | +$368K | 0.26% | 105 |
|
|
2021
Q4 | $267K | Buy |
+3,023
| New | +$267K | 0.15% | 243 |
|
|
2021
Q2 | – | Sell |
-6,947
| Closed | -$525K | – | 823 |
|
|
2021
Q1 | $525K | Buy |
+6,947
| New | +$525K | 0.26% | 84 |
|